Diagnostic classification of schizophrenia by neural network analysis of blood-based gene expression signatures

Schizophrenia Research

Volumn 119, Issue 1-3, 2010, Pages 210-218

  Takahashi, Makoto ^a   Hayashi, Hiroshi ^b   Watanabe, Yuichiro ^a   Sawamura, Kazushi ^a   Fukui, Naoki ^a   Watanabe, Junzo ^a   Kitajima, Tsuyoshi ^c,d   Yamanouchi, Yoshio ^c,d   Iwata, Nakao ^c,d   Mizukami, Katsuyoshi ^e   Hori, Takafumi ^e   Shimoda, Kazutaka ^f   Ujike, Hiroshi ^g   Ozaki, Norio ^d,h   Iijima, Kentarou ^b   Takemura, Kazuo ^b   Aoshima, Hideyuki ^b   Someya, Toshiyuki ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^b SRL INC   (Japan)

^c FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^e UNIVERSITY OF TSUKUBA   (Japan)

^f DOKKYO MEDICAL UNIVERSITY   (Japan)

^g OKAYAMA UNIVERSITY   (Japan)

^h NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Artificial neural network; Bioinformatics; Biomarker; CDNA microarray; Schizophrenia

Indexed keywords

CYCLIN DEPENDENT KINASE 2; DEXTRO AMINO ACID OXIDASE; METHIONYL AMINOPEPTIDASE; METHIONYL AMINOPEPTIDASE 1D; NERVE CELL ADHESION MOLECULE L1; NEUROGENIN 1; NICOTINIC RECEPTOR BETA2; PROGESTERONE RECEPTOR; SOMATOMEDIN BINDING PROTEIN 3; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN; ZINC FINGER PROTEIN 74;

ADULT; ARTICLE; ARTIFICIAL NEURAL NETWORK; BIOINFORMATICS; CLUSTER ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DNA MICROARRAY; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE PROBE; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; ONSET AGE; PREDICTION; PRIORITY JOURNAL; SCHIZOPHRENIA; UPREGULATION;

ADULT; BRAIN; FEMALE; GENE EXPRESSION PROFILING; GENETIC MARKERS; HUMANS; MALE; MIDDLE AGED; NEURAL NETWORKS (COMPUTER); OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 77952674096     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2009.12.024     Document Type: Article

References (39)

1. Aston C., Jiang L., Sokolov B.P. Microarray analysis of postmortem temporal cortex from patients with schizophrenia. J. Neurosci. Res. 2004, 77(6):858-866.
2. Cheung V.G., Conlin L.K., Weber T.M., Arcaro M., Jen K.Y., Morley M., Spielman R.S. Natural variation in human gene expression assessed in lymphoblastoid cells. Nat. Genet. 2003, 33(3):422-425.
3. Chumakov I., Blumenfeld M., Guerassimenko O., Cavarec L., Palicio M., Abderrahim H., Bougueleret L., Barry C., Tanaka H., La Rosa P., Puech A., Tahri N., Cohen-Akenine A., Delabrosse S., Lissarrague S., Picard F.P., Maurice K., Essioux L., Millasseau P., Grel P., Debailleul V., Simon A.M., Caterina D., Dufaure I., Malekzadeh K., Belova M., Luan J.J., Bouillot M., Sambucy J.L., Primas G., Saumier M., Boubkiri N., Martin-Saumier S., Nasroune M., Peixoto H., Delaye A., Pinchot V., Bastucci M., Guillou S., Chevillon M., Sainz-Fuertes R., Meguenni S., Aurich-Costa J., Cherif D., Gimalac A., Van Duijn C., Gauvreau D., Ouellette G., Fortier I., Raelson J., Sherbatich T., Riazanskaia N., Rogaev E., Raeymaekers P., Aerssens J., Konings F., Luyten W., Macciardi F., Sham P.C., Straub R.E., Weinberger D.R., Cohen N., Cohen D. Genetic and physiological data implicating the new human gene G72 and the gene for d-amino acid oxidase in schizophrenia. Proc. Natl. Acad. Sci. U. S. A. 2002, 99(21):13,675-13,680.
4. De Bruyne V., Al-Mulla F., Pot B. Methods for microarray data analysis. Methods Mol. Biol. 2007, 382:373-391.
5. Debey S., Schoenbeck U., Hellmich M., Gathof B.S., Pillai R., Zander T., Schultze J.L. Comparison of different isolation techniques prior gene expression profiling of blood derived cells: impact on physiological responses, on overall expression and the role of different cell types. Pharmacogenomics J. 2004, 4(3):193-207.
6. Eady J.J., Wortley G.M., Wormstone Y.M., Hughes J.C., Astley S.B., Foxall R.J., Doleman J.F., Elliott R.M. Variation in gene expression profiles of peripheral blood mononuclear cells from healthy volunteers. Physiol. Genomics 2005, 22(3):402-411.
7. Hakak Y., Walker J.R., Li C., Wong W.H., Davis K.L., Buxbaum J.D., Haroutunian V., Fienberg A.A. Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc. Natl. Acad. Sci. U. S. A. 2001, 98(8):4746-4751.
8. Hashimoto K., Fukushima T., Shimizu E., Komatsu N., Watanabe H., Shinoda N., Nakazato M., Kumakiri C., Okada S., Hasegawa H., Imai K., Iyo M. Decreased serum levels of d-serine in patients with schizophrenia: evidence in support of the N-methyl-d-aspartate receptor hypofunction hypothesis of schizophrenia. Arch. Gen. Psychiatry 2003, 60(6):572-576.
9. Hemby S.E., Ginsberg S.D., Brunk B., Arnold S.E., Trojanowski J.Q., Eberwine J.H. Gene expression profile for schizophrenia: discrete neuron transcription patterns in the entorhinal cortex. Arch. Gen. Psychiatry 2002, 59(7):631-640.
10. Huang da W., Sherman B.T., Tan Q., Kir J., Liu D., Bryant D., Guo Y., Stephens R., Baseler M.W., Lane H.C., Lempicki R.A. DAVID Bioinformatics Resources: expanded annotation database and novel algorithms to better extract biology from large gene lists. Nucleic Acids Res. 2007, 35:W169-W175. Web Server issue.
11. Iwamoto K., Kato T. Gene expression profiling in schizophrenia and related mental disorders. Neuroscientist 2006, 12(4):349-361.
12. Iwamoto K., Kakiuchi C., Bundo M., Ikeda K., Kato T. Molecular characterization of bipolar disorder by comparing gene expression profiles of postmortem brains of major mental disorders. Mol. Psychiatry 2004, 9(4):406-416.
13. Iwamoto K., Bundo M., Kato T. Altered expression of mitochondria-related genes in postmortem brains of patients with bipolar disorder or schizophrenia, as revealed by large-scale DNA microarray analysis. Hum. Mol. Genet. 2005, 14(2):241-253.
14. Jaeger J., Sengupta R., Ruzzo W.L. Improved gene selection for classification of microarrays. Pac. Symp. Biocomput. 2003, 53-64.
15. Khan J., Wei J.S., Ringner M., Saal L.H., Ladanyi M., Westermann F., Berthold F., Schwab M., Antonescu C.R., Peterson C., Meltzer P.S. Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks. Nat. Med. 2001, 7(6):673-679.
16. Lancashire L.J., Rees R.C., Ball G.R. Identification of gene transcript signatures predictive for estrogen receptor and lymph node status using a stepwise forward selection artificial neural network modelling approach. Artif. Intell. Med. 2008, 43(2):99-111.
17. Li Q. Improvement of bias and generalizability for computer-aided diagnostic schemes. Comput. Med. Imaging Graph. 2007, 31(4-5):338-345.
18. Li J., Liu H., Ng S.K., Wong L. Discovery of significant rules for classifying cancer diagnosis data. Bioinformatics 2003, 19(Suppl 2):ii93-ii102.
19. Lin Y.H., Friederichs J., Black M.A., Mages J., Rosenberg R., Guilford P.J., Phillips V., Thompson-Fawcett M., Kasabov N., Toro T., Merrie A.E., van Rij A., Yoon H.S., McCall J.L., Siewert J.R., Holzmann B., Reeve A.E. Multiple gene expression classifiers from different array platforms predict poor prognosis of colorectal cancer. Clin. Cancer Res. 2007, 13(2):498-507.
20. Liu B., Cui Q., Jiang T., Ma S. A combinational feature selection and ensemble neural network method for classification of gene expression data. BMC Bioinformatics 2004, 5(136):1-12.
21. Middleton F.A., Pato C.N., Gentile K.L., McGann L., Brown A.M., Trauzzi M., Diab H., Morley C.P., Medeiros H., Macedo A., Azevedo M.H., Pato M.T. Gene expression analysis of peripheral blood leukocytes from discordant sib-pairs with schizophrenia and bipolar disorder reveals points of convergence between genetic and functional genomic approaches. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2005, 136B(1):12-25.
22. Mirnics K., Middleton F.A., Marquez A., Lewis D.A., Levitt P. Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex. Neuron 2000, 28(1):53-67.
23. Mirnics K., Middleton F.A., Stanwood G.D., Lewis D.A., Levitt P. Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia. Mol. Psychiatry 2001, 6(3):293-301.
24. Mothet J.P., Parent A.T., Wolosker H., Brady R.O., Linden D.J., Ferris C.D., Rogawski M.A., Snyder S.H. d-serine is an endogenous ligand for the glycine site of the N-methyl-d-aspartate receptor. Proc. Natl. Acad. Sci. U. S. A. 2000, 97(9):4926-4931.
25. Ohmori T., Morita K., Saito T., Ohta M., Ueno S., Rokutan K. Assessment of human stress and depression by DNA microarray analysis. J. Med. Invest. 2005, 52:266-271. Suppl.
26. Vawter M.P., Ferran E., Galke B., Cooper K., Bunney W.E., Byerley W. Microarray screening of lymphocyte gene expression differences in a multiplex schizophrenia pedigree. Schizophr. Res. 2004, 67(1):41-52.
27. O'Neill M.C., Song L. Neural network analysis of lymphoma microarray data: prognosis and diagnosis near-perfect. BMC Bioinformatics 2003, 4(13):1-12.
28. Radich J.P., Mao M., Stepaniants S., Biery M., Castle J., Ward T., Schimmack G., Kobayashi S., Carleton M., Lampe J., Linsley P.S. Individual-specific variation of gene expression in peripheral blood leukocytes. Genomics 2004, 83(6):980-988.
29. Rainen L., Oelmueller U., Jurgensen S., Wyrich R., Ballas C., Schram J., Herdman C., Bankaitis-Davis D., Nicholls N., Trollinger D., Tryon V. Stabilization of mRNA expression in whole blood samples. Clin. Chem. 2002, 48(11):1883-1890.
30. Rhodes D.R., Yu J., Shanker K., Deshpande N., Varambally R., Ghosh D., Barrette T., Pandey A., Chinnaiyan A.M. Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression. Proc. Natl. Acad. Sci. U. S. A. 2004, 101(25):9309-9314.
31. Schwarz E., Bahn S. The utility of biomarker discovery approaches for the detection of disease mechanisms in psychiatric disorders. Br. J. Pharmacol. 2008, 153(Suppl 1):S133-S136.
32. Storey J.D., Tibshirani R. Statistical significance for genomewide studies. Proc. Natl. Acad. Sci. U. S. A. 2003, 100(16):9440-9445.
33. Sugai T., Kawamura M., Iritani S., Araki K., Makifuchi T., Imai C., Nakamura R., Kakita A., Takahashi H., Nawa H. Prefrontal abnormality of schizophrenia revealed by DNA microarray: impact on glial and neurotrophic gene expression. Ann. N.Y. Acad. Sci. 2004, 1025:84-91.
34. Sullivan P.F., Fan C., Perou C.M. Evaluating the comparability of gene expression in blood and brain. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2006, 141B(3):261-268.
35. Tkachev D., Mimmack M.L., Ryan M.M., Wayland M., Freeman T., Jones P.B., Starkey M., Webster M.J., Yolken R.H., Bahn S. Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet 2003, 362(9386):798-805.
36. Tsuang M.T., Nossova N., Yager T., Tsuang M.M., Guo S.C., Shyu K.G., Glatt S.J., Liew C.C. Assessing the validity of blood-based gene expression profiles for the classification of schizophrenia and bipolar disorder: a preliminary report. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2005, 133B(1):1-5.
37. Whitney A.R., Diehn M., Popper S.J., Alizadeh A.A., Boldrick J.C., Relman D.A., Brown P.O. Individuality and variation in gene expression patterns in human blood. Proc. Natl. Acad. Sci. U. S. A. 2003, 100(4):1896-1901.
38. Xu Y., Selaru F.M., Yin J., Zou T.T., Shustova V., Mori Y., Sato F., Liu T.C., Olaru A., Wang S., Kimos M.C., Perry K., Desai K., Greenwald B.D., Krasna M.J., Shibata D., Abraham J.M., Meltzer S.J. Artificial neural networks and gene filtering distinguish between global gene expression profiles of Barrett's esophagus and esophageal cancer. Cancer Res. 2002, 62(12):3493-3497.
39. Zvara A., Szekeres G., Janka Z., Kelemen J.Z., Cimmer C., Santha M., Puskas L.G. Over-expression of dopamine D2 receptor and inwardly rectifying potassium channel genes in drug-naive schizophrenic peripheral blood lymphocytes as potential diagnostic markers. Dis. Markers 2005, 21(2):61-69.